Munich, Germany, April 23, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and ...
"Pitolisant GR remains on track for NDA submission this quarter with a target PDUFA date in Q1 2027," said President, CEO & Director Dayno, while Executive VP and Chief Medical & Scientific Officer ...
The combined Pd-Au-Pt expression at Skaergaard — already one of the world’s largest undeveloped precious-metals systems — just stepped up by approximately 50% in the high-price sensitivity sceanario ...
I tested Tractive and Fi Mini smart collars for months on my cat Basil to find which was superior for activity, sleep, and ...
Aim This study aims to systematically evaluate the effects of palliative care on the quality of life, anxiety level, depression level, cardiac function, readmission rate and mortality rate among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results